CG MedTech Co.,Ltd. (KOSDAQ:056090)

South Korea · Delayed Price · Currency is KRW

1,165.00

+26.00 (2.28%)

At close: Sep 4, 2026

CG MedTech Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	51,199	47,235	34,623	34,969	41,169	38,055
Revenue Growth	19.80%	36.43%	-0.99%	-15.06%	8.18%	37.01%
Gross Profit	21,049	20,863	15,789	17,829	18,651	15,484
Operating Income	1,876	3,802	-1,096	2,204	-10,177	-815.21
Net Income	6,554	6,508	59.69	1,629	-18,540	-4,970
Earnings Per Share	64.55	63.02	1.00	20.65	-279.00	-112.00
EPS Growth	125.67%	6202.12%	-95.16%	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	10,752	10,844	34,299	14,348	74,987	20,187
Total Debt	20,512	4,309	4,431	4,367	66,009	29,975
Net Cash (Debt)	-9,759	6,535	29,867	9,981	8,977	-9,788
Net Cash Growth	-	-78.12%	199.24%	11.18%	-	-
Net Cash Per Share	-96.13	63.29	500.36	126.54	134.93	-219.88

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1,914	2,613	1,511	-2,478	-5,365	1,237
Capital Expenditures	-20,863	-11,479	-773.97	-1,590	-819.5	-862.16
Free Cash Flow	-22,777	-8,866	736.7	-4,068	-6,184	375.08
Free Cash Flow Growth	-	-	-	-	-	-80.72%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	41.11%	44.17%	45.60%	50.99%	45.30%	40.69%
Operating Margin	3.66%	8.05%	-3.17%	6.30%	-24.72%	-2.14%
Pretax Margin	5.36%	5.79%	0.04%	3.97%	-44.75%	-14.20%
Profit Margin	12.80%	13.78%	0.17%	4.66%	-45.03%	-13.06%
FCF Margin	-44.49%	-18.77%	2.13%	-11.63%	-15.02%	0.99%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	18.05	18.53	1743.71	57.14	-	-
Forward PE	-	26.54	26.54	26.54	26.54	26.54
P/FCF Ratio	-	-	141.29	-	-	120.94
PS Ratio	2.35	2.55	3.01	2.66	2.26	1.19